Widening Spectrum of a Reversible Splenial Lesion with Transiently Reduced Diffusion

References

1. ↵
   Kim SS, Chang K-H, Kim ST, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol 1999;20:125–29

   Abstract/FREE Full Text
2. ↵
   Mirsattari SM, Lee DH, Jones MW, et al. Transient lesion in the splenium of the corpus callosum in an epileptic patient. Neurology 2003;60:1838–41

   Abstract/FREE Full Text
3. ↵
   Tada H, Takanashi J, Barkovich AJ, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 2004;63:1854–58

   Abstract/FREE Full Text
4. ↵
   Takanashi J, Barkovich AJ, Yamaguchi K, et al. Influenza encephalopathy with a reversible lesion in the splenium of the corpus callosum. AJNR Am J Neuroradiol 2004;25:798–802

   Abstract/FREE Full Text
5. ↵
   Kobuchi N, Tsukahara H, Kawamura Y, et al. Reversible diffusion-weighted MR findings of Salmonella enteritidis–associated encephalopathy. Eur Neurol 2003;49:182–84

   CrossRefPubMedWeb of Science
6. ↵
   Dyken PR. Viral diseases of the nervous system. In: Swaiman KF, ed. Pediatric neurology. 2nd ed. St. Louis: Mosby;1994 :643–88
7. ↵
   Barkovich AJ. Toxic and metabolic brain disorders. In: Barkovich AJ, ed. Pediatric neuroimaging. 3rd ed. New York: Lippincott Williams & Wilkins;2000 :71–156
8. ↵
   Friese SA, Bitzer M, Freudenstein D, et al. Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology 2000;42:795–802

   CrossRefPubMedWeb of Science